Published in World J Gastroenterol on October 28, 2006
Intestinal metaplasia -the effect of Acid on the gastric mucosa and gastric carcinogenesis-. J Toxicol Pathol (2010) 0.82
Is Helicobacter pylori Infection the Primary Cause of Duodenal Ulceration or a Secondary Factor? A Review of the Evidence. Gastroenterol Res Pract (2013) 0.78
Cross-reactivity of anti-H pylori antibodies with membrane antigens of human erythrocytes. World J Gastroenterol (2007) 0.78
Role of dietary phospholipids and phytosterols in protection against peptic ulceration as shown by experiments on rats. World J Gastroenterol (2015) 0.77
Restoring psychology's role in peptic ulcer. Appl Psychol Health Well Being (2012) 0.77
A Case of Small Bowel Ulcer Associated with Helicobacter pylori. Pediatr Gastroenterol Hepatol Nutr (2012) 0.75
A tribute to Dr. Frank I Tovey on his 90th birthday. World J Gastroenterol (2011) 0.75
Dietary Phytosterols Protective Against Peptic Ulceration. Gastroenterology Res (2011) 0.75
Helicobacter pylori test and treat versus proton pump inhibitor: Role of H pylori in dyspepsia. BMJ (2008) 0.75
Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet (1984) 32.58
Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet (1990) 9.49
Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med (1993) 6.61
Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet (1989) 6.58
Antibody to the gastric campylobacter-like organism ("Campylobacter pyloridis")--clinical correlations and distribution in the normal population. J Med Microbiol (1986) 4.95
Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study. Lancet (1987) 4.32
Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology (1995) 3.28
Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med (1994) 3.19
Helicobacter pylori: the African enigma. Gut (1992) 3.06
Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology (1996) 2.67
Low prevalence of Helicobacter pylori in an Australian duodenal ulcer population: NSAIDitis or the effect of ten years of H. pylori treatment? Aust N Z J Med (1998) 2.46
Duodenal ulcer in black populations in Africa south of the Sahara. Gut (1975) 2.29
Peptic ulcer in India and Bangladesh. Gut (1979) 2.20
Review article: Helicobacter pylori eradication--understandable caution but no excuse for inertia. Aliment Pharmacol Ther (1994) 2.07
Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults. Gastroenterology (2001) 1.88
Helicobacter pylori is killed by nitrite under acidic conditions. Gut (1998) 1.82
Duodenal ulcer, Helicobacter pylori, and gastric secretion. Gut (1994) 1.75
Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J Clin Gastroenterol (1997) 1.74
Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials. Am J Gastroenterol (1998) 1.73
Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection. Gut (1993) 1.64
Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated. Am J Gastroenterol (1999) 1.51
Prevalence of Helicobacter pylori in peptic ulcer disease in a Singapore hospital. Singapore Med J (2000) 1.45
H. pylori, the most common bacterial infection in Africa: a random serological study. Am J Gastroenterol (1992) 1.43
Helicobacter pylori and recurrent ulceration after highly selective vagotomy. Eur J Gastroenterol Hepatol (1995) 1.42
Possible dietary protective factors in relation to the distribution of duodenal ulcer in India and Bangladesh. Gut (1980) 1.36
Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study. Gastroenterology (1997) 1.31
Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified? Am J Gastroenterol (1998) 1.22
Helicobacter pylori-negative duodenal ulcer. Am J Gastroenterol (1991) 1.19
Helicobacter pylori infection in north-eastern peninsular Malaysia. Evidence for an unusually low prevalence. Scand J Gastroenterol (1994) 1.19
Helicobacter pylori and gastritis in patients with peptic ulcer and non-ulcer dyspepsia: ethnic differences in Singapore. Gut (1990) 1.16
Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers. Gastroenterology (1995) 1.14
Helicobacter pylori in Africa: observations on an 'enigma within an enigma'. J Gastroenterol Hepatol (1999) 1.14
Non-Helicobacter pylori and non-NSAID peptic ulcer disease in the Japanese population. Eur J Gastroenterol Hepatol (2000) 1.13
Clinical and endoscopic characteristics of non-Helicobacter pylori, non-NSAID duodenal ulcers: a long-term prospective study. Aliment Pharmacol Ther (2001) 1.11
Ulcer recurrence after gastric surgery: is Helicobacter pylori the culprit? Am J Gastroenterol (1998) 1.11
Demographic and endoscopic characteristics of patients with Helicobacter pylori positive and negative peptic ulcer disease. Med J Aust (2000) 1.11
Campylobacter pylori, gastritis, and peptic ulcer disease in central Africa. Br Med J (Clin Res Ed) (1987) 1.11
Factors affecting growth and antibiotic susceptibility of Helicobacter pylori: effect of pH and urea on the survival of a wild-type strain and a urease-deficient mutant. J Med Microbiol (1996) 1.08
Helicobacter pylori--an African perspective. QJM (2001) 1.08
Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics, and prognosis--results from a randomized trial with 2-year follow-up. Am J Gastroenterol (2001) 1.07
The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe. Helicobacter (2004) 1.05
The prevalence of Helicobacter pylori infection in the Peoples Republic of China. Am J Gastroenterol (1991) 1.04
Antibody response to Campylobacter pylori in an ethnic group lacking peptic ulceration. Scand J Infect Dis (1988) 1.03
Recurrent peptic ulcers in patients following successful Helicobacter pylori eradication: a multicenter study of 4940 patients. Helicobacter (2004) 1.02
Differential north to south gastric cancer-duodenal ulcer gradient in China. China Ulcer Study Group. J Gastroenterol Hepatol (1998) 1.02
The ulcerogenic and protective action of rice and rice fractions in experimental peptic ulceration. Clin Sci (Lond) (1987) 1.01
Endoscopic findings and prevalence of Helicobacter pylori in Kenyan patients with dyspepsia. East Afr Med J (1998) 1.01
A molecular basis of peptic ulceration due to diet. Br J Exp Pathol (1986) 0.99
[Helicobacter pylori after proximal selective vagotomy]. Vnitr Lek (1992) 0.98
Prevalence of Helicobacter pylori infection in disorders of the upper gastrointestinal tract in south India. Natl Med J India (1998) 0.93
Role of Helicobacter pylori infection in perforation of peptic ulcer: an age- and gender-matched case-control study. J Clin Gastroenterol (1997) 0.93
Prevalence and risk factors of Helicobacter pylori-negative peptic ulcer: a multicenter study. J Clin Gastroenterol (2000) 0.92
Helicobacter pylori-negative duodenal ulcer. Am J Med (1991) 0.92
The prevalence of symptoms of dyspepsia in north eastern Nigeria. A random community based survey. Trop Geogr Med (1992) 0.91
Helicobacter pylori eradication in the African setting, with special reference to reinfection and duodenal ulcer recurrence. Gut (1995) 0.91
Further evidence for an exceptionally low prevalence of Helicobacter pylori infection among peptic ulcer patients in north-eastern peninsular Malaysia. Trans R Soc Trop Med Hyg (2001) 0.91
Duodenal ulcer prevalence: experimental evidence for the possible role of dietary lipids. J Gastroenterol Hepatol (2000) 0.90
Eradication of Helicobacter pylori and prevention of recurrence of duodenal ulcer: a randomized, double-blind, multi-centre trial of omeprazole with or without clarithromycin. Aliment Pharmacol Ther (1995) 0.90
Duodenal ulcer in China. J Gastroenterol Hepatol (1992) 0.88
Duodenal gastric metaplasia and Helicobacter pylori infection in high and low duodenal ulcer-prevalent areas in India. J Gastroenterol Hepatol (2004) 0.88
Duodenal ulcer prevalence: research into the nature of possible protective dietary lipids. Phytother Res (2003) 0.88
Helicobacter pylori associated with a high prevalence of duodenal ulcer disease and a low prevalence of gastric cancer in a developing nation. Gut (1995) 0.88
Prevalence of Helicobacter pylori in southern Indian controls and patients with gastroduodenal disease. J Gastroenterol Hepatol (1995) 0.87
Helicobacter pylori infection inhibits healing of the wounded duodenal epithelium in vitro. J Lab Clin Med (2003) 0.87
Risk factors for duodenal ulcer in north India. Trop Gastroenterol (1999) 0.87
Co-screening for primary biliary cirrhosis and coeliac disease. Helicobacter pylori: the African enigma. Gut (1998) 0.86
What is the role of Helicobacter pylori in peptic ulcer and gastric cancer outside the big cities? J Clin Gastroenterol (1998) 0.86
Helicobacter pylori-negative peptic ulcer in Japan: which contributes most to peptic ulcer development, Helicobacter pylori, NSAIDS or stress? J Gastroenterol (2000) 0.86
Dietary factors in relation to the distribution of duodenal ulcer in India as assessed by studies in rats. J Gastroenterol Hepatol (2001) 0.85
Does the declining prevalence of Helicobacter pylori unmask patients with idiopathic peptic ulcer disease? Trends over an 8 year period. Eur J Gastroenterol Hepatol (2004) 0.84
Helicobacter pylori infection after partial gastrectomy for peptic ulcer and its role in relapsing disease. Eur J Gastroenterol Hepatol (1997) 0.84
Campylobacter pylori in central Africa. Br Med J (Clin Res Ed) (1988) 0.83
Helicobacter pylori infection in patients with ulcer recurrence after partial gastrectomy. Hepatogastroenterology (2004) 0.83
H. pylori-negative duodenal ulcer prevalence and causes in 774 patients. Dig Dis Sci (1999) 0.83
Ideology of Helicobacter pylori prevalence in peptic ulcer disease in an inner-city minority population. J Clin Gastroenterol (2004) 0.82
Helicobacter pylori infection and gastric autoimmune diseases: is there a link? Helicobacter (2003) 0.82
Duodenal ulcer in South Africa: home-pounded versus milled maize. J Gastroenterol Hepatol (2005) 0.82
Possible absence of Helicobacter pylori in the early stages of duodenal ulceration. QJM (2002) 0.82
Campylobacter pylori in dyspeptic subjects: a report from north India. Trans R Soc Trop Med Hyg (1990) 0.81
Helicobacter pylori in recently-diagnosed versus chronic duodenal ulcer. Acta Gastroenterol Latinoam (1996) 0.81
Frequency of Helicobacter pylori infection in dyspeptic patients in Libya. Saudi Med J (2002) 0.81
Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease. A randomized trial with 2-year follow-up. The Danish Ulcer Study Group. Scand J Gastroenterol (2000) 0.80
Prevalence of Helicobacter pylori infection in patients with peptic ulcer diseases and non-ulcer dyspepsia. Korean J Intern Med (1993) 0.80
Detection of Helicobacter pylori in endoscopic biopsies in Sudan. Trop Doct (1994) 0.80
The course of Helicobacter pylori infection after partial gastrectomy for peptic ulcer disease. Hepatogastroenterology (1998) 0.80
Helicobacter pylori epidemiology in relation to peptic ulcer and gastric cancer in south and north China. J Gastroenterol Hepatol (1994) 0.80
Helicobacter pylori virulence factors in duodenal ulceration: A primary cause or a secondary infection causing chronicity. World J Gastroenterol (2006) 0.80
Helicobacter pylori test-and-eradication strategy. Lancet (2000) 0.79
Helicobacter pylori infection and subsequent peptic duodenal disease among young adults. Int J Epidemiol (2000) 0.79
Link between Helicobacter pylori-associated gastritis and duodenal ulcer. Dig Dis Sci (1993) 0.79
Helicobacter pylori infection in patients with perforated duodenal ulcer. Trop Gastroenterol (1998) 0.78
Is Helicobacter pylori-negative duodenal ulcer masked by the high prevalence of H. pylori infection in the general population? Am J Gastroenterol (1999) 0.78
[Helicobacter pylori colonization in surgical patients]. Chirurg (1991) 0.78
Duodenal ulcer relapse is not always associated with recurrence of H. pylori infection: a prospective three-year follow-up study. Helicobacter (1999) 0.77
[Clinical investigation of perforated duodenal ulcer--with special reference to the presence of Helicobacter pylori infection and rate of recurrence]. Nihon Shokakibyo Gakkai Zasshi (2002) 0.76
Peptic ulcer recurrence after Helicobacter pylori eradication: a 5-year follow-up study. Eur J Gastroenterol Hepatol (1995) 0.76
[Role of Helicobacter pylori in the etiology of duodenal ulcer recurrence after selective proximal vagotomy]. Khirurgiia (Mosk) (1996) 0.76
Double-blind, multicenter, placebo-controlled evaluation of clarithromycin and omeprazole for Helicobacter pylori-associated duodenal ulcer. Helicobacter (1996) 0.76
A study of Helicobacter pylori infection in patients with pernicious anemia. Folia Med (Plovdiv) (2000) 0.76
Helicobacter pylori after surgery for duodenal ulcer. Hepatogastroenterology (1997) 0.76
Susceptibility of Helicobacter pylori to metronidazole. Am J Gastroenterol (2003) 1.98
Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease? Dig Dis Sci (2004) 1.51
Intestinal tuberculosis. Curr Opin Infect Dis (2009) 1.47
A comparison amongst three rapid urease tests to diagnose Helicobacter pylori infection in 375 consecutive dyspeptic. Intern Emerg Med (2010) 1.46
Inflammatory bowel disease: is the intestine a Trojan horse? Sci Prog (2002) 1.22
Diagnosis of Helicobacter pylori: invasive and non-invasive tests. Best Pract Res Clin Gastroenterol (2007) 1.19
Human domain antibodies against virulence traits of Candida albicans inhibit fungus adherence to vaginal epithelium and protect against experimental vaginal candidiasis. J Infect Dis (2006) 1.11
Helicobacter: a paradigm shift in peptic ulcer disease and more? Sci Prog (2002) 1.09
Does Helicobacter pylori really cause duodenal ulcers? No. BMJ (2009) 1.05
Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori. World J Gastroenterol (2005) 1.05
Post-gastrectomy patients need to be followed up for 20-30 years. World J Gastroenterol (2000) 1.01
Widespread occurrence of Mycobacterium tuberculosis DNA from 18th-19th century Hungarians. Am J Phys Anthropol (2003) 0.95
Helicobacter pylori and gastric cancer: neither friend nor foe. Gastroenterology (2007) 0.94
High prevalence of primary antibiotic resistance in Helicobacter pylori isolates in Italy. J Gastrointestin Liver Dis (2012) 0.92
Innate immunity and pathogen-host interaction. Vaccine (2003) 0.91
Morphology of segmented filamentous bacteria and their patterns of contact with the follicle-associated epithelium of the mouse terminal ileum: implications for the relationship with the immune system. Gut Microbes (2011) 0.89
Duodenal ulcer prevalence: research into the nature of possible protective dietary lipids. Phytother Res (2003) 0.88
Controversies in the Helicobacter pylori/duodenal ulcer story. Trans R Soc Trop Med Hyg (2008) 0.83
Cholera-like enterotoxins and Regulatory T cells. Toxins (Basel) (2010) 0.82
Presence of Helicobacter pylori in betel chewers and non betel chewers with and without oral cancers. BMC Oral Health (2009) 0.82
Actual concept of "probiotics": is it more functional to science or business? World J Gastroenterol (2013) 0.82
A human domain antibody and Lewis b glycoconjugate that inhibit binding of Helicobacter pylori to Lewis b receptor and adhesion to human gastric epithelium. J Infect Dis (2009) 0.81
Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori. J Antimicrob Chemother (2003) 0.80
Helicobacter pylori virulence factors in duodenal ulceration: A primary cause or a secondary infection causing chronicity. World J Gastroenterol (2006) 0.80
Comparison of image analysis software packages in the assessment of adhesion of microorganisms to mucosal epithelium using confocal laser scanning microscopy. J Microbiol Methods (2005) 0.79
Is Helicobacter pylori Infection the Primary Cause of Duodenal Ulceration or a Secondary Factor? A Review of the Evidence. Gastroenterol Res Pract (2013) 0.78
Structural bacterial molecules as potential candidates for an evolution of the classical concept of probiotics. Adv Nutr (2011) 0.77
Use of a single biopsy specimen for diagnosing Helicobacter pylori infection by culture and two different PCR methods: report from Cuba. Trop Gastroenterol (2010) 0.77
Clinical presentation and risk factors of inflammatory bowel disease in Sri Lanka. Trop Gastroenterol (2011) 0.76
Helicobacter pylori test and treat versus proton pump inhibitor: Role of H pylori in dyspepsia. BMJ (2008) 0.75
Helicobacter pylori: current status and future prospects. Sci Prog (2004) 0.75
Meeting the needs of the pay-at-the-pump generation. Health Manag Technol (2002) 0.75
Role of Helicobacter pylori infection in the thyroid diseases. J Gastrointestin Liver Dis (2013) 0.75
Colonization by Helicobacter pylori of leprosy patients in Spain: immunomodulation to low molecular weight antigens of H. pylori. Mem Inst Oswaldo Cruz (2010) 0.75